Cargando…
Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19
INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127522/ http://dx.doi.org/10.1016/j.acvdsp.2021.04.089 |
_version_ | 1783693964924157952 |
---|---|
author | De Poortere, J. Dechamps, M. Laterre, P.F. Octave, M. Ginion, A. Robaux, V. Pirotton, L. Bodart, J. Gerard, L. Gruson, D. Van Dievoet, M.A. Douxfils, J. Derive, M. Gatto, L. Martin, M. Bouzin, C. Castanares-Zapatero, D. Bertrand, L. Horman, S. Beauloye, C. |
author_facet | De Poortere, J. Dechamps, M. Laterre, P.F. Octave, M. Ginion, A. Robaux, V. Pirotton, L. Bodart, J. Gerard, L. Gruson, D. Van Dievoet, M.A. Douxfils, J. Derive, M. Gatto, L. Martin, M. Bouzin, C. Castanares-Zapatero, D. Bertrand, L. Horman, S. Beauloye, C. |
author_sort | De Poortere, J. |
collection | PubMed |
description | INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial activation and procoagulant state with microvascular thrombi inducing disseminated intravascular coagulation (DIC). Although CAC and DIC induce altered coagulation responses, their clinical outcomes are different. OBJECTIVE: We investigated and compared coagulopathy between septic shock and critical COVID-19 patients. METHOD: Septic shock patients were diagnosed following the Survival Sepsis Campaign guidelines. COVID-19 patients were admitted in intensive care unit (ICU) for severe acute respiratory distress syndrome. Both were included in the study within 2 days after admission. Biomarkers were measured by ELISA from patient's plasma. RESULTS: We observed an increase in vWF and TFPI in both septic and COVID-19 patients compared to controls, highlighting endothelial damage. Interestingly, circulating TF was only elevated in COVID-19 patients. Platelet activation differed between the two cohorts of patients. P-selectin and TLT-1 were specifically heightened in septic shock whereas CD40L was only augmented in COVID-19. Coagulation markers were increased in a disease-dependent way, with PAI-1, tPA and D-Dimers higher in septic shock and fibrinogen level, higher in COVID-19. DISCUSSION: COVID-19 patients had longer length-of-stay with more pronounced respiratory failure. This strong lung disruption overtime induced plasmatic TF release with sustained inflammatory response characterized by sCD40L and fibrinogen secretion. Given the similarities between COVID-19 and septic shock regarding fibrinolysis and coagulation, but not platelet activation, endothelium seems to play a central role in COVID-19 and might explain the differences between CAC and DIC. |
format | Online Article Text |
id | pubmed-8127522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Masson SAS |
record_format | MEDLINE/PubMed |
spelling | pubmed-81275222021-05-18 Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 De Poortere, J. Dechamps, M. Laterre, P.F. Octave, M. Ginion, A. Robaux, V. Pirotton, L. Bodart, J. Gerard, L. Gruson, D. Van Dievoet, M.A. Douxfils, J. Derive, M. Gatto, L. Martin, M. Bouzin, C. Castanares-Zapatero, D. Bertrand, L. Horman, S. Beauloye, C. Archives of Cardiovascular Diseases. Supplements 342 INTRODUCTION: Host immune response to the coronavirus disease 2019 (COVID-19) is variable and can induce a dysregulated inflammatory response associated with venous and arterial thrombosis called COVID-19 associated coagulopathy (CAC). During septic shock, inflammatory reaction generates endothelial activation and procoagulant state with microvascular thrombi inducing disseminated intravascular coagulation (DIC). Although CAC and DIC induce altered coagulation responses, their clinical outcomes are different. OBJECTIVE: We investigated and compared coagulopathy between septic shock and critical COVID-19 patients. METHOD: Septic shock patients were diagnosed following the Survival Sepsis Campaign guidelines. COVID-19 patients were admitted in intensive care unit (ICU) for severe acute respiratory distress syndrome. Both were included in the study within 2 days after admission. Biomarkers were measured by ELISA from patient's plasma. RESULTS: We observed an increase in vWF and TFPI in both septic and COVID-19 patients compared to controls, highlighting endothelial damage. Interestingly, circulating TF was only elevated in COVID-19 patients. Platelet activation differed between the two cohorts of patients. P-selectin and TLT-1 were specifically heightened in septic shock whereas CD40L was only augmented in COVID-19. Coagulation markers were increased in a disease-dependent way, with PAI-1, tPA and D-Dimers higher in septic shock and fibrinogen level, higher in COVID-19. DISCUSSION: COVID-19 patients had longer length-of-stay with more pronounced respiratory failure. This strong lung disruption overtime induced plasmatic TF release with sustained inflammatory response characterized by sCD40L and fibrinogen secretion. Given the similarities between COVID-19 and septic shock regarding fibrinolysis and coagulation, but not platelet activation, endothelium seems to play a central role in COVID-19 and might explain the differences between CAC and DIC. Published by Elsevier Masson SAS 2021-05 2021-05-17 /pmc/articles/PMC8127522/ http://dx.doi.org/10.1016/j.acvdsp.2021.04.089 Text en Copyright © 2021 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 342 De Poortere, J. Dechamps, M. Laterre, P.F. Octave, M. Ginion, A. Robaux, V. Pirotton, L. Bodart, J. Gerard, L. Gruson, D. Van Dievoet, M.A. Douxfils, J. Derive, M. Gatto, L. Martin, M. Bouzin, C. Castanares-Zapatero, D. Bertrand, L. Horman, S. Beauloye, C. Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title | Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title_full | Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title_fullStr | Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title_full_unstemmed | Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title_short | Head-to-head comparison of cytokines storm-coagulopathy in septic shock and COVID-19 |
title_sort | head-to-head comparison of cytokines storm-coagulopathy in septic shock and covid-19 |
topic | 342 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127522/ http://dx.doi.org/10.1016/j.acvdsp.2021.04.089 |
work_keys_str_mv | AT depoorterej headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT dechampsm headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT laterrepf headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT octavem headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT giniona headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT robauxv headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT pirottonl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT bodartj headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT gerardl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT grusond headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT vandievoetma headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT douxfilsj headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT derivem headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT gattol headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT martinm headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT bouzinc headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT castanareszapaterod headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT bertrandl headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT hormans headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 AT beauloyec headtoheadcomparisonofcytokinesstormcoagulopathyinsepticshockandcovid19 |